Compounds > alpha-cyano-4-hydroxycinnamate
Page last updated: 2024-10-22

alpha-cyano-4-hydroxycinnamate and Ischemia

alpha-cyano-4-hydroxycinnamate has been researched along with Ischemia in 1 studies

alpha-cyano-4-hydroxycinnamate: specific inhibitor of pyruvate transport in rat liver mitochondria & human erythrocytes; structure

Ischemia: A hypoperfusion of the BLOOD through an organ or tissue caused by a PATHOLOGIC CONSTRICTION or obstruction of its BLOOD VESSELS, or an absence of BLOOD CIRCULATION.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Melena, J1
Safa, R1
Graham, M1
Casson, RJ1
Osborne, NN1

Other Studies

1 other study available for alpha-cyano-4-hydroxycinnamate and Ischemia

ArticleYear
The monocarboxylate transport inhibitor, alpha-cyano-4-hydroxycinnamate, has no effect on retinal ischemia.
    Brain research, 2003, Oct-31, Volume: 989, Issue:1

    Topics: Animals; Coumaric Acids; Ischemia; Monocarboxylic Acid Transporters; Rats; Rats, Wistar; Retina

2003